Aug 06, 2020
Real Madrid star Kroos names dream farewell XI for final game including Cristiano Ronaldo as his ‘best ever’ team-mate
This news has been received from: the-sun.com
All trademarks, copyrights, videos, photos and logos are owned by respective news sources. News stories, videos and live streams are from trusted sources.
TONI KROOS has named his dream, all-time XI including "best-ever" former team-mate Cristiano Ronaldo.
The German legend, 30, was speaking on the Einfach Mal Luppen podcast with his brother.4Toni Kroos has named this team as his dream, all-time XI 4Toni Kroos has called Cristiano Ronaldo 'the best player he's ever played with'Credit: Reuters
Kroos was asked who he would pick in his fantasy XI if he could play alongside ANYONE for his last-ever game of football.
And the Los Blancos playmaker listed a host of stars from his days at Real Madrid and the German national team.
In goal, Kroos opted for German icon Manuel Neuer behind s 3-2-2-3 formation.
Despite Real Madrid being lauded as having one of the best defences in the world, up there with Liverpool, just one Bernabeu defender made the back-three.
Sergio Ramos was given a starting spot by Kroos - with the German calling him "one of the best central defenders of all time".
The Spaniard starts alongside former Bayer Leverkusen pals Gonzalo Castro and Stefan Reinartz in the dream team.
Germany team-mate Joshua Kimmich was given the nod alongside Real pal Casemiro in the defensive midfield ranks.
And Kroos picked Bernabeu buddy and 2018 Ballon d'Or winner Luka Modric to start alongside in the more advanced midfield roles.4Toni Kroos listed a host of current Real Madrid stars, including Luka ModricCredit: Reuters 4Kroos also picked a hatful of his old Bayern Munich pals, including Neuer and MullerCredit: EPA Most read in FootballPicturedGEORGEOUS Georgina Rodriguez puts on VERY racy display in tiny black lace bodysuit'AGENT RIO'Ferdinand hints at Sancho transfer after finding old tweet from Dortmund starPicturedSOR SUBJECTNeymar's ex-girlfriend Soraja Vucelic almost pops out of dress in steamy selfiePicturedTOP FORMBrazil icon Ronaldo soaks up sun with partner Celina Locks on yacht in FormenteraLive BlogBLUES NEWSChelsea transfer news LIVE: Havertz deal LATEST, Willian move updatesTOP OF TH£ FLOP$Most expensive flop XI in history as £505k-a-week Sanchez nears Utd exit
Up front, Ronaldo - who Kroos described as "the best player I've played with" - starts on the left flank.
Thomas Muller - a third current Bayern Munich star in the team - starts on the right flank.
And retired Germany legend Miroslav Klose was named as his sole striker.Cristiano Ronaldo's girlfriend Georgina Rodriguez wows fans as she shares saucy workout video on Instagram
News Source: the-sun.com
BioNTech plans share sale in which Pfizer would present a large order
By Caroline Copley and Arno Schuetze
BERLIN / FRANKFURT, Jul 21 (.) – German biotech company BioNTech said on Tuesday it plans to raise cash with a stock sale in which its partner in the development of a coronavirus vaccine, Pfizer Inc, will become a shareholder .
The rights offering announcement is the latest in a series of funding activities this week around German biotech companies seeking to develop potential coronavirus vaccines.
BioNTech shares, whose market capitalization reaches $ 21 billion, rose 7% to $ 94.47 at 1400 GMT.
BioNTech said in a statement that it plans to sell 5 million shares – worth $ 472 million at the current market price – and that Pfizer placed an order for $ 200 million. The sale is likely to be done at a discount, said one person knowledgeable.
The Moderna company raised capital in May for $ 1.3 billion at a 5% discount.
Earlier Tuesday, German biotech CureVac said the Qatari sovereign wealth fund (QIA) acquired a stake as part of a $ 126 million financing round.
The announcement came a day after British pharmaceutical company GSK took a 10% stake in exchange for a $ 171 million investment.
Both companies compete with Moderna, AstraZeneca and others in developing a vaccine for the coronavirus, which causes COVID-19. Respiratory disease has caused more than 600,000 deaths worldwide.
BioNTech and Pfizer said Monday that data from an initial trial phase of their experimental vaccine showed that it produced an immune response and was well tolerated, results similar to those seen in a previous test.
Technically, BioNtech is offering rights to buy about 4 million shares, after 74.83% of its existing shareholders agreed not to exercise or transfer their rights. The rest of the rights will go to the remaining shareholders, who can exercise or sell them.
(Report by Caroline Copley and Arno Schuetze; Edited in Spanish by Ricardo Figueroa)